Suven Pharma Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA457674
EBIT426635
Earning Per Share1417
Expenses569741
Net Profit309413
Net Profit Margin3131
Operating Profit Margin4551
Profit Before Tax414626
Dividends Per Share25
Operation Revenue1,0241,413

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023008,560.84NA9,408.43
2023002,835.49NA4,038.35
202300372.90NA385.50
202300103.87NA140.39
20221,257.602,182.90978.507,628.101,190
The EBITDA of Suven Pharma is 674 as of 12/3/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
2019201920192023
Operating Activities505050451
Investing Activities-65-65-65-195
Financing Activities262626-236
Others0000
Net Cash Flow11111120

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20234,959.33-7,943.682,376.07-608.28
20223,325.90-1,871.88-1,599.79-145.77
2023723.95-447.59-261.9614.40
2020140.90-44.50-38.5557.85
2017640-498.50-177.50-36
The cash flow from Operating Activities of Suven Pharma is 451 as of 12/3/2023